ofloxacin has been researched along with metronidazole in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.48) | 18.7374 |
1990's | 13 (10.74) | 18.2507 |
2000's | 61 (50.41) | 29.6817 |
2010's | 42 (34.71) | 24.3611 |
2020's | 2 (1.65) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Citron, DM; Goldstein, EJ | 1 |
Brousil, L; Heinigeová, B; Potuzník, V | 1 |
Beerens, H; Devos, J; Dubreuil, L; Romond, C | 1 |
Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
Brook, I; Ledney, GD | 1 |
Barry, AL; Brown, SD | 1 |
Hecht, DW; Osmolski, JR | 1 |
Beger, HG; Isenmann, R; Meyer, H; Schwarz, M | 1 |
Bertram, P; Schumpelick, V; Töns, C; Winkeltau, GJ | 1 |
Carta, A; Casalta, JP; La Scola, B; Musso, D; Piquet, P | 1 |
Edlund, C; Nord, CE; Sabouri, S | 1 |
Dick, T; Lee, BH; Murugasu-Oei, B | 1 |
Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
Chandeying, V; Geater, A; Kemapunmanus, M; Law, M; Rowe, P; Skov, S | 1 |
Degener, JE; Hendriks, B; Noordhoek, GT; Terpstra, S; Voesten, HG | 1 |
Appelbaum, PC; Credito, KL; Jacobs, MR | 1 |
Kane, KY; Pierce, R | 1 |
Beger, HG; Ebeling, P; Isenmann, R; Schwarz, M; Thomsen, J; Weikert, E | 1 |
Bharani, A; Kumar, H | 1 |
Beger, HG; Gaus, W; Isenmann, R; Schwarz, M; Thomsen, J | 1 |
Schwebke, JR; Weiss, HL | 1 |
Haruma, K; Hirakawa, K; Hoshika, K; Iida, M; Koga, H; Mikami, Y; Shimizu, K; Yao, T | 1 |
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E | 1 |
Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME | 1 |
Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D | 1 |
Akao, T; He, JX; Tani, T | 1 |
Chen, J; Ge, JH; Mai, ED; Su, QZ; Zhang, QM | 1 |
Campeau, NG; Heaney, CJ; Lindell, EP | 1 |
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
Avorn, J; Fischer, MA; Solomon, DH; Teich, JM | 1 |
Chuah, SK; Gollapudi, S; Thadepalli, H | 1 |
Bauhofer, A; Celik, I; Plaul, U; Torossian, A; Wulf, H | 1 |
Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T | 1 |
Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P | 1 |
Danziger, LH; Gotfried, MH; Graham, MB; Hackett, S; Pendland, SL; Quinn, JP; Rodvold, KA; Schriever, CA; Sprandel, KA | 1 |
Deyo, K; Rodvold, KA; Sibley, C; Sprandel, KA; Styrczula, DE | 1 |
Hermsen, ED; Hovde, LB; Rodvold, KA; Rotschafer, JC; Sprandel, KA | 1 |
Arthurs, M; Barton, EN; Dowe, G; Lee, MG; Levy, V; Smikle, MF | 1 |
Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Perna, F; Ricci, C; Tampieri, A; Vaira, D; Zullo, A | 1 |
Aoyama, N; Kasuga, M; Matsumoto, Y; Miki, I; Mitani, T; Miyachi, H; Morita, Y; Shirasaka, D; Tamura, T; Toyoda, M; Watanabe, Y | 1 |
Fakokunde, A; Gyang, A; Kalu, E; Whitlow, B | 1 |
Hu, J; Wang, L; Wei, H; Yang, L; Zhong, H | 1 |
Chen, SW; Shen, ZJ; Wang, H; Zhao, JP; Zhou, XL | 1 |
Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK | 1 |
Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F | 1 |
Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P | 1 |
Branda, JA; Gibbons, FK; Shepard, JA | 1 |
Alefelder, M; Arvis, P; Cronjé, HS; Kureishi, A; Paszkowski, T; Rakoczi, I; Reimnitz, P; Ross, JD; Vildaite, D | 1 |
Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA | 1 |
Mondschein, JI; Patel, S; Soulen, MC; Tuite, CM | 1 |
Hassan, C; Morini, S; Perna, F; Ricci, C; Saracino, I; Vaira, D; Zullo, A | 1 |
Hassoun, A; Ibrahim, F | 1 |
Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
Ness, RB; Roberts, MS; Smith, KJ; Wiesenfeld, HC | 1 |
Abdelmoula, L; Ben Hadj Yahia, C; Chaabouni, L; Manamani, L; Saidane, O; Tekaya, R; Zouari, R | 1 |
Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D | 1 |
Hagymási, K; Tulassay, Z | 1 |
Biswas, NK; Chandel, DS; Duggal, N; Duggal, S; Hans, C; Mahajan, RK | 1 |
Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ | 1 |
Pezzilli, R | 1 |
Gu, CP; Huang, LP; Zhuang, ML | 1 |
Bhan-Kotwal, S; Carmaciu, CD; Jenkins, HS; Koul, S | 1 |
Judlin, P; Thiebaugeorges, O | 1 |
Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ | 1 |
Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L | 1 |
Katelaris, PH | 1 |
Kandulski, A; Malfertheiner, P; Selgrad, M | 1 |
Aoun, O; Barruet, R; Ficko, C; Imbert, P; Méchaï, F; Rapp, C | 1 |
Angelini, R; Pontone, P; Pontone, S; Standoli, M | 1 |
Cristofari, F; De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Panella, C; Perna, F; Vaira, D; Vannella, L; Zullo, A | 1 |
Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N | 1 |
Boothby, M; Page, J; Pryor, R; Ross, JD | 1 |
Hibi, T; Nishizawa, T; Suzuki, H | 1 |
Akopian, TA; Chelysheva, VV; Govorun, VM; Momynaliev, KT; Selezneva, OV | 1 |
D'Ercole, C; De Francesco, V; Hassan, C; Vaira, D; Zullo, A | 1 |
Hsueh, PR; Lee, PI; Yang, JC | 1 |
Arvis, P; Hampel, B; Judlin, P; Liao, Q; Liu, Z; Reimnitz, P | 1 |
Gu, WQ; Liang, X; Liu, WZ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
Lochmannová, J | 1 |
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
Goh, KL; Navaratnam, P | 1 |
Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR | 1 |
Feldman, D; Sarabanchong, VO; Treszezamsky, AD | 1 |
Chiu, YC; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Tai, WC; Wu, DC; Wu, KL | 1 |
Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M | 1 |
Bohbot, JM | 1 |
Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC | 1 |
Mossa, HA; Salem, AA | 1 |
D'Arcy, S; Glocker, E; Lasseter, G; Lawson, AJ; McNulty, CA; Nichols, T; Shaw, I | 1 |
Andersen, LP; Coenen, S; Glupczynski, Y; Goossens, H; Hirschl, AM; Kist, M; Lopez-Brea, M; Megraud, F; Versporten, A | 1 |
Chen, YH; Chuah, SK; Hsieh, MC; Hsu, PI; Hu, HM; Kuo, CH; Kuo, FC; Liu, CJ; Tseng, HH; Wang, SS; Wu, DC | 1 |
Bourret, A; Brun, JL; Fauconnier, A | 1 |
Ge, X; Sun, H; Wang, H | 1 |
Andreeva, IV; Belikov, AN; Evstaf'ev, VV; Fokin, AA; Grinev, AV; Khrianin, AA; Kirpicheva, NN; Korolev, SV; Kozlov, SN; Serdiutskaia, MV; Stetsiuk, OU | 1 |
Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC | 1 |
Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A | 1 |
Gisbert, JP; Marin, AC; McNicholl, AG | 1 |
Hensel, DJ; Scurlock, AM; Woods, JL | 1 |
Ark, C; Aşicioğlu, O; Ertas, IE; Gungorduk, K; Ozdemir, A; Sanci, M; Yildirim, G | 1 |
Ang, TL; Song, M | 1 |
Esfahani, HM; Kargosha, K; Rashvand, M; Salemi, A; Vosough, M | 1 |
Agostini, A; Bourret, A; Brun, JL; Derniaux, E; Fauconnier, A; Garbin, O; Graesslin, O; Huchon, C; Judlin, P; Lamy, C; Quentin, R; Verdon, R | 1 |
Chen, JZ; Gratrix, J; Parker, P; Read, R; Singh, AE; Smyczek, P | 1 |
Cheng, NS; Hu, HJ; Li, FY; Ma, WJ; Shi, YJ; Wang, JK; Wu, ZR; Yang, Q | 1 |
Dean, G; Pitt, R; Ross, J; Sabin, C; Soni, S; Whetham, J | 1 |
14 review(s) available for ofloxacin and metronidazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical inquiries. What are the most effective treatments for bacterial vaginosis in nonpregnant women?
Topics: Administration, Oral; Adult; Antifungal Agents; Clindamycin; Evidence-Based Medicine; Female; Guidelines as Topic; Humans; Metronidazole; Ofloxacin; Treatment Outcome; Vaginosis, Bacterial | 2001 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2006 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
[The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Patient Compliance; Proton Pump Inhibitors; Risk Factors; Salvage Therapy; Treatment Failure | 2008 |
Helicobacter pylori: diagnosis and treatment.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Treatment Failure | 2009 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
[Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors | 2010 |
[New options for helicobacter pylori antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure | 2011 |
A new look at anti-Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline | 2011 |
[Management of uncomplicated pelvic inflammatory disease].
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; France; Gonorrhea; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Ofloxacin; Pelvic Inflammatory Disease; Sexual Partners; Tissue Adhesions | 2012 |
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2013 |
Second and third line treatment options for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Moxifloxacin; Ofloxacin; Rifabutin; Rifamycins; Rifaximin; Salvage Therapy; Virulence Factors | 2014 |
Updated French guidelines for diagnosis and management of pelvic inflammatory disease.
Topics: Anti-Infective Agents; Ceftriaxone; Disease Management; Drug Therapy, Combination; Female; France; Humans; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease; Pelvis; Practice Guidelines as Topic; Societies, Medical; Ultrasonography | 2016 |
25 trial(s) available for ofloxacin and metronidazole
Article | Year |
---|---|
[Antibiotic use in necrotizing pancreatitis. Results of a controlled study].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Biopsy, Needle; Drug Therapy, Combination; Humans; Injections, Intravenous; Metronidazole; Middle Aged; Ofloxacin; Pancreas; Pancreatitis, Acute Necrotizing; Prospective Studies; Treatment Outcome | 1997 |
Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand.
Topics: Adult; Anti-Infective Agents; Candidiasis, Vulvovaginal; Clinical Protocols; Doxycycline; Female; Gonorrhea; Humans; Leukorrhea; Metronidazole; Microbiological Techniques; Middle Aged; Nystatin; Ofloxacin; Physical Examination; Trichomonas Vaginitis; Uterine Cervicitis; Vaginosis, Bacterial | 1998 |
Efficacy of oral ofloxacin for single-dose perioperative prophylaxis in general surgery--a controlled randomized clinical study.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Colon; Female; Humans; Injections, Intravenous; Male; Metronidazole; Mezlocillin; Middle Aged; Ofloxacin; Pancreas; Surgical Wound Infection | 2001 |
Interrelationships of bacterial vaginosis and cervical inflammation.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Female; Humans; Metronidazole; Ofloxacin; Uterine Cervicitis; Vaginosis, Bacterial | 2002 |
[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacteriological Techniques; Bile; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Data Interpretation, Statistical; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Levofloxacin; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Time Factors | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 2004 |
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Bacteria, Anaerobic; Bacteroides; Biotransformation; Chromatography, High Pressure Liquid; Creatinine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Escherichia coli; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Peptostreptococcus | 2004 |
Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies | 2005 |
[Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Prostatic Diseases; Ultrasonography, Interventional; Urinary Tract Infections | 2001 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2006 |
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Ofloxacin; Pain; Pain Measurement; Pelvic Inflammatory Disease; Prospective Studies; Quinolines | 2006 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult | 2009 |
Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease; Sexually Transmitted Diseases; Vaginosis, Bacterial | 2009 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Middle Aged; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Treatment Outcome; Young Adult | 2010 |
Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2011 |
Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin | 2013 |
Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial.
Topics: Adolescent; Adult; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Ofloxacin; Patient Compliance; Pelvic Inflammatory Disease; Quinolines | 2013 |
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Metronidazole; Middle Aged; Mycoplasma genitalium; Ofloxacin; Pelvic Inflammatory Disease; Treatment Outcome; Young Adult | 2021 |
82 other study(ies) available for ofloxacin and metronidazole
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.
Topics: Abdomen; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Drug Synergism; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 1991 |
[Ofloxacin and metronidazole in short-term prophylaxis of septic complications after hepatocholedochal surgery].
Topics: Aged; Aged, 80 and over; Biliary Tract Surgical Procedures; Drug Therapy, Combination; Female; Humans; Infection Control; Male; Metronidazole; Middle Aged; Ofloxacin; Postoperative Complications | 1989 |
[In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; Bifidobacterium; Clostridium; Drug Synergism; Eubacterium; Fusobacterium; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Peptococcaceae; Propionibacterium acnes; Veillonella | 1988 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation | 1994 |
Anaerobic activity of levofloxacin and metronidazole separately and in combination.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Therapy, Combination; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 1996 |
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1996 |
[Stage-oriented antibiotic therapy of peritonitis. Prospective study].
Topics: Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Metronidazole; Ofloxacin; Peritoneal Lavage; Peritonitis; Prognosis; Prospective Studies; Surgical Wound Infection; Survival Analysis | 1997 |
Aortoabdominal aneurysm infected by Yersinia enterocolitica serotype O:9.
Topics: Aged; Aneurysm, Infected; Anti-Infective Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Brucella; Cross Reactions; Drug Therapy, Combination; Humans; Leukocyte Count; Male; Metronidazole; Ofloxacin; Penicillins; Piperacillin; Tomography, X-Ray Computed; Yersinia enterocolitica; Yersinia Infections | 1997 |
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins | 1998 |
Oxygen depletion induced dormancy in Mycobacterium smegmatis.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cell Division; DNA, Bacterial; Drug Resistance, Microbial; Humans; Metronidazole; Mycobacterium; Ofloxacin; Oxygen; RNA, Bacterial | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Base Sequence; Coagulase; DNA Fingerprinting; DNA Primers; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Ofloxacin; Polymerase Chain Reaction; Skin; Staphylococcus; Time Factors | 1999 |
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Clindamycin; Drug Combinations; Drug Synergism; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 2000 |
Pharmacokinetic basis for oral perioperative prophylaxis with ofloxacin in general surgery.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Humans; Injections, Intravenous; Metronidazole; Mezlocillin; Ofloxacin; Penicillins; Preoperative Care; Risk Factors; Treatment Outcome | 2001 |
Drug points: Diabetes inspidus induced by ofloxacin.
Topics: Adult; Anti-Infective Agents, Urinary; Clarithromycin; Diabetes Insipidus; Drug Therapy, Combination; Gentamicins; Humans; Male; Metronidazole; Ofloxacin; Penicillin G; Pneumonia, Pneumococcal | 2001 |
Does metronidazole cure cap polyposis by its antiinflammatory actions instead of by its antibiotic action? A case study.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Child; Colon; Colonic Polyps; Colonoscopy; Female; Humans; Intestinal Mucosa; Metronidazole; Ofloxacin | 2002 |
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2002 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy | 2003 |
Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Benzoates; Biotransformation; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drug Combinations; Feces; Glucosides; Male; Medicine, Kampo; Metronidazole; Monoterpenes; Ofloxacin; Penicillins; Rats; Rats, Wistar | 2003 |
[Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
Topics: Chemistry, Pharmaceutical; Fiber Optic Technology; Metronidazole; Nitrofurantoin; Ofloxacin; Optical Fibers; Solubility; Tablets; Transducers | 2003 |
MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity.
Topics: Abdominal Abscess; Abdominal Neoplasms; Aged; Amoxicillin; Anti-Infective Agents; Carcinoid Tumor; Cerebellar Ataxia; Cerebellar Nuclei; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysarthria; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Metronidazole; Neurotoxicity Syndromes; Ofloxacin; Remission, Spontaneous | 2003 |
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.
Topics: Administration, Oral; Amiodarone; Drug Therapy, Computer-Assisted; Fluconazole; Humans; Infusions, Intravenous; Levofloxacin; Medication Systems, Hospital; Metronidazole; Ofloxacin; Practice Patterns, Physicians'; Ranitidine; Reminder Systems | 2003 |
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines | 2004 |
Effects of G-CSF and antibiotic prophylaxis in a 2 x 2 factorial design on outcome in septic rats.
Topics: Abdomen; Animals; Antibiotic Prophylaxis; Cefuroxime; Clinical Trials as Topic; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Male; Metronidazole; Ofloxacin; Rats; Rats, Wistar; Reproducibility of Results; Sepsis; Survival Analysis; Treatment Outcome | 2004 |
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2004 |
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
Topics: Chemistry, Pharmaceutical; Dosage Forms; Drug Incompatibility; Drug Stability; Humans; Infusions, Intravenous; Levofloxacin; Metronidazole; Ofloxacin; Temperature; Time Factors | 2005 |
Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Chromatography, High Pressure Liquid; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Half-Life; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Ofloxacin; Quinolines | 2005 |
Antibiotic sensitivity of Helicobacter pylori in Jamaica.
Topics: Aged; Breath Tests; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Jamaica; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Evaluation; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2005 |
Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Infective Agents; Ascites; Clarithromycin; Diagnosis, Differential; Female; Fever; Humans; Metronidazole; Ofloxacin; Pancreatitis; Postpartum Period; Treatment Outcome | 2005 |
Life-threatening meningitis resulting from transrectal prostate biopsy.
Topics: Adenocarcinoma; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biopsy; Escherichia coli Infections; Humans; Levofloxacin; Male; Meningitis; Metronidazole; Ofloxacin; Prostatic Neoplasms; Ultrasound, High-Intensity Focused, Transrectal | 2005 |
Case records of the Massachusetts General Hospital. Case 12-2006. A 37-year-old man with hemoptysis and a pulmonary infiltrate.
Topics: Adult; Anti-Infective Agents; Diagnosis, Differential; Hemoptysis; Humans; Lung; Lung Neoplasms; Male; Metronidazole; Mycobacterium tuberculosis; Ofloxacin; Pneumonia; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Pulmonary | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biliary Tract Diseases; Case-Control Studies; Chemoembolization, Therapeutic; Drainage; Drug Therapy, Combination; Erythromycin; Humans; Levofloxacin; Liver Abscess; Liver Function Tests; Metronidazole; Neomycin; Ofloxacin; Retrospective Studies; Risk Factors; Stents | 2006 |
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2007 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cost-Benefit Analysis; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Humans; Markov Chains; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease | 2007 |
[Clostridium clostridiiforme vertebral osteomyelitis].
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clostridium; Clostridium Infections; Drug Therapy, Combination; Humans; Immunocompetence; Male; Metronidazole; Ofloxacin; Osteomyelitis; Spine; Treatment Outcome | 2008 |
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure | 2008 |
Splenic abscess due to Salmonella enterica Serotype typhi in a young adult.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Ceftriaxone; Humans; Male; Metronidazole; Ofloxacin; Salmonella typhi; Spleen; Splenic Diseases; Typhoid Fever; Young Adult | 2008 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis as Topic; Metronidazole; Ofloxacin; Pancreatitis; Randomized Controlled Trials as Topic | 2009 |
[Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 2009 |
Organic psychosis induced by ofloxacin and metronidazole.
Topics: Adolescent; Anti-Infective Agents; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Female; Humans; Metronidazole; Ofloxacin; Psychoses, Substance-Induced; Risperidone; Treatment Outcome; Urinary Tract Infections | 2009 |
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult | 2009 |
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome | 2010 |
Helicobacter pylori: antibiotic resistance and treatment options.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure | 2009 |
Budd-Chiari syndrome as a vascular complication of amebic liver abscess.
Topics: Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Budd-Chiari Syndrome; Enoxaparin; Humans; Liver Abscess, Amebic; Male; Metronidazole; Ofloxacin; Phenindione | 2009 |
Helicobacter pylori antibiotic resistance and [13C]urea breath test values.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Statistics as Topic; Urea; Urease | 2010 |
Antibiotic resistance of Helicobacter pylori in Israeli children.
Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure | 2010 |
A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.
Topics: Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Middle Aged; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2010 |
[Biological cost of rifampicin resistance in Helicobacter pylori].
Topics: Adaptation, Biological; Anti-Bacterial Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Genes, Bacterial; Helicobacter pylori; Metronidazole; Mutation; Ofloxacin | 2009 |
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tinidazole; Young Adult | 2010 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Retrospective Studies; Young Adult | 2010 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies | 2011 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean Section; Chorioamnionitis; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Postoperative Complications; Postpartum Period; Pregnancy; Streptococcal Infections; Streptococcus anginosus; Surgical Wound Dehiscence; Uterus; Vasculitis | 2011 |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland | 2011 |
[Chlamydia trachomatis: The enemy of the Fallopian tube].
Topics: Adolescent; Adult; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Fallopian Tube Diseases; Female; Humans; Infertility, Female; Metronidazole; Ofloxacin; Prevalence; Young Adult | 2011 |
Method validation and determinations of levofloxacin, metronidazole and sulfamethoxazole in an aqueous pharmaceutical, urine and blood plasma samples using quantitative nuclear magnetic resonance spectrometry.
Topics: Humans; Levofloxacin; Magnetic Resonance Spectroscopy; Maleates; Metronidazole; Ofloxacin; Sensitivity and Specificity; Sulfamethoxazole; Temperature | 2012 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Risk Factors; Wales | 2012 |
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Utilization; Europe; Female; Helicobacter pylori; Humans; Infant; Infant, Newborn; Levofloxacin; Linear Models; Logistic Models; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Ofloxacin; Prospective Studies; Risk Factors; Surveys and Questionnaires; Young Adult | 2013 |
Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography.
Topics: Ceftriaxone; Chromatography, High Pressure Liquid; Ethylamines; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Levofloxacin; Methanol; Metronidazole; Ofloxacin; Phosphates; Potassium Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Cross-Sectional Studies; Doxycycline; Fluconazole; Guideline Adherence; Humans; Josamycin; Male; Metronidazole; Middle Aged; Mycoplasma genitalium; Mycoplasma hominis; Ofloxacin; Polymerase Chain Reaction; Practice Guidelines as Topic; Retrospective Studies; Russia; Trichomonas vaginalis; Ureaplasma urealyticum; Urethra; Urethritis | 2012 |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult | 2013 |
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Child; Diagnosis, Differential; Diagnostic Errors; Doxycycline; Ethnicity; Female; Guideline Adherence; Humans; International Classification of Diseases; Levofloxacin; Metronidazole; Ofloxacin; Outpatient Clinics, Hospital; Pain; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Sexually Transmitted Diseases; Symptom Assessment; United States; Uterine Cervicitis; Young Adult | 2013 |
Direct analysis of six antibiotics in wastewater samples using rapid high-performance liquid chromatography coupled with diode array detector: a chemometric study towards green analytical chemistry.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Green Chemistry Technology; Metronidazole; Ofloxacin; Sulfadiazine; Sulfamerazine; Sulfamethoxazole; Wastewater; Water Pollutants, Chemical | 2015 |
Gonococcal and Chlamydial Cases of Pelvic Inflammatory Disease at 2 Canadian Sexually Transmitted Infection Clinics, 2004 to 2014: A Retrospective Cross-sectional Review.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Canada; Chlamydia Infections; Cross-Sectional Studies; Female; Gonorrhea; Humans; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease; Retrospective Studies; Treatment Failure; Young Adult | 2018 |
Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Chlorhexidine; Cholangitis; Chronic Disease; Collagen Type I; Cytokines; Drug Combinations; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Lithiasis; Liver Diseases; Metronidazole; Neomycin; Nitrofurazone; Ofloxacin; Polymyxin B; Povidone-Iodine; Rabbits; Therapeutic Irrigation; Vascular Endothelial Growth Factor A | 2020 |